Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|February 21, 2018
Current Status of Gene Engineering Cell TherapeuticsAurore Saudemont, Laurent Jespers, Timothy ClayBMJ Case Reports|February 6, 2024
Advanced thymic carcinoma with a hepatic metastasis treated with chemotherapy and staged resectionSheldon Russell, Suresh Navadgi, Timothy Clay, et al.Current Molecular Medicine|August 20, 2009
Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppressionBenjamin Johnson, Takuya Osada, Timothy Clay, et al.Cancer Immunology, Immunotherapy : CII|November 8, 2005
NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activityTakuya Osada, Timothy Clay, Amy Hobeika, et al.Nature Clinical Practice. Oncology|November 3, 2005
Recent developments in therapeutic cancer vaccinesMichael A Morse, Stephen Chui, Amy Hobeika, et al.Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in colon cancerMichael Morse, Lee Langer, Alexander Starodub, et al.Expert Opinion on Biological Therapy|April 13, 2010
Adenovirus vaccine immunotherapy targeting WT1-expressing tumorsJeffrey M Clarke, Michael A Morse, H Kim Lyerly, et al.Human Gene Therapy|October 7, 2020
Short Time to Market and Forward Planning Will Enable Cell Therapies to Deliver R&D Pipeline ValueDelfi Krishna, Laure Rittié, Hoang Tran, et al.Molecular Cancer Therapeutics|January 19, 2008
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expressionKatherine M Aird, Xiuyun Ding, Aris Baras, et al.Cancer Immunology, Immunotherapy : CII|January 15, 2008
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patientsTakuya Osada, Gabriel Chong, Robert Tansik, et al.Pageof 2